What's Up, Corporate Finance?
“Will it Get Better Again? Our M&A Outlook for 2024” With Dr. Christian Zuleger
December 12, 2023
Our partner Dr. Christian Zuleger was a guest in the 100th edition of the podcast What's Up, Corporate Finance? As an authority on the M&A market, he spoke with host Bastian Frien about key learnings from 2023 and promising market trends in the small, mid and large cap segment. Topics include the changing preferences in the area of ESG funds and the increasing acceptance of buy-and-build-strategies. In addition to Mr. Zuleger, Jürgen Zapf (Alvarez & Marsal) and Dr. Sven Oleownik (EMERAM) provide interesting insights into the development of the market.
*Please note that the podcast is available in German only
Author: Bastian Frien
Quotes from Dr. Christian Zuleger
- “In the large cap segment in particular, fund managers have a smaller number of promising targets at their disposal. As a result, we see that they prefer to realize an increase in value and therefore place their targets in a continuation fund.”
- “W&I insurance is becoming increasingly relevant, especially for financial investors. This means that due diligence is becoming more complex because insurance companies are carrying out more detailed checks.”
- “We observe traditional and diversified financial investors increasingly moving into the ESG sector and favoring such assets over other segments.”
- “Transactions in the small cap market are showing an increasing degree of creativity. U.S. investors, who have already successfully implemented various buy-and-build-strategies in highly fragmented sectors in their home market, are now bringing these approaches to Europe.”
Capabilities
Suggested News & Insights
Sidley Elects Partnership Class of 29 and Counsel Class of 15 Across Europe and U.S.December 11, 2025Sidley Represents Capricor Therapeutics in US$172.5 Million Common Stock OfferingDecember 10, 2025Sidley Represents Lido Advisors in Its Partnership With Stuart Chaussée & AssociatesDecember 10, 2025Sidley Represents Lumexa Imaging in US$462.5 Million Initial Public OfferingDecember 10, 2025Sidley Advises Bessemer Investors on Strategic Investment in XanitosDecember 9, 2025Sidley Advises Ancala on Acquisition of U.S. Chemical Infrastructure PortfolioDecember 4, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
